89 related articles for article (PubMed ID: 34944112)
1. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Exerted Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor.
Tanaka T; Ohishi T; Saito M; Suzuki H; Kaneko MK; Kawada M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):142-149. PubMed ID: 35666554
[TBL] [Abstract][Full Text] [Related]
2. Defucosylated Mouse-Dog Chimeric Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H77Bf) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma.
Nanamiya R; Ohishi T; Suzuki H; Mizuno T; Yoshikawa T; Asano T; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2023 Feb; 42(1):27-33. PubMed ID: 36399552
[TBL] [Abstract][Full Text] [Related]
3. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Mouse-Dog Chimeric Anti-HER2 Monoclonal Antibody (H77Bf).
Suzuki H; Asano T; Ohishi T; Yoshikawa T; Suzuki H; Mizuno T; Tanaka T; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2023 Feb; 42(1):34-40. PubMed ID: 36383106
[TBL] [Abstract][Full Text] [Related]
4. Defucosylated Monoclonal Antibody (H
Suzuki H; Ohishi T; Nanamiya R; Kawada M; Kaneko MK; Kato Y
Curr Issues Mol Biol; 2023 Sep; 45(10):7734-7748. PubMed ID: 37886932
[TBL] [Abstract][Full Text] [Related]
5. A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models.
Suzuki H; Ohishi T; Kaneko MK; Kato Y
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894446
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma.
Kamoto S; Shinada M; Kato D; Yoshimoto S; Ikeda N; Tsuboi M; Yoshitake R; Eto S; Hashimoto Y; Takahashi Y; Chambers J; Uchida K; Kaneko MK; Fujita N; Nishimura R; Kato Y; Nakagawa T
Cells; 2020 Nov; 9(11):. PubMed ID: 33238582
[TBL] [Abstract][Full Text] [Related]
7. Re: Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs.
Farrell M; Adams R; von Pfeil DJF
Vet J; 2024 Apr; 305():106104. PubMed ID: 38580157
[TBL] [Abstract][Full Text] [Related]
8. Current Targeted Therapy for Metastatic Colorectal Cancer.
Ohishi T; Kaneko MK; Yoshida Y; Takashima A; Kato Y; Kawada M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675216
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models.
Li G; Suzuki H; Ohishi T; Asano T; Tanaka T; Yanaka M; Nakamura T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
Int J Mol Med; 2023 Feb; 51(2):. PubMed ID: 36660940
[TBL] [Abstract][Full Text] [Related]
10. A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG
Asano T; Tanaka T; Suzuki H; Li G; Ohishi T; Kawada M; Yoshikawa T; Kaneko MK; Kato Y
Antibodies (Basel); 2022 Nov; 11(4):. PubMed ID: 36546899
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma.
Tateyama N; Suzuki H; Ohishi T; Asano T; Tanaka T; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432687
[TBL] [Abstract][Full Text] [Related]
12. Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
Suzuki H; Ohishi T; Asano T; Tanaka T; Saito M; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856438
[TBL] [Abstract][Full Text] [Related]
13. Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors.
Li G; Ohishi T; Kaneko MK; Takei J; Mizuno T; Kawada M; Saito M; Suzuki H; Kato Y
Cells; 2021 Dec; 10(12):. PubMed ID: 34944112
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf).
Li G; Suzuki H; Takei J; Asano T; Sano M; Tanaka T; Harada H; Mizuno T; Ohishi T; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):53-58. PubMed ID: 35471048
[TBL] [Abstract][Full Text] [Related]
15. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody (134-mG
Nanamiya R; Takei J; Ohishi T; Asano T; Tanaka T; Sano M; Nakamura T; Yanaka M; Handa S; Tateyama N; Harigae Y; Saito M; Suzuki H; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Feb; 41(1):1-7. PubMed ID: 35225663
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]